MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ARQT
  4. News
ARQT
Quote
Short
News
Articles
Message Board

Arcutis Biotherapeutics Inc. (NASDAQ : ARQT ) News

Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) News Releases

ARQT News Releases
ARQT : NASDAQ
SeekingAlpha
Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
ARQT : NASDAQ
GlobeNewswire
Arcutis Announces Promotion of Mas Matsuda to Executive Vice President and Chief Legal Officer to Support Next Phase of Growth
ARQT : NASDAQ
SeekingAlpha
Baron Health Care Fund Q4 2025 Recent Activity
ARQT : NASDAQ
GlobeNewswire
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
ARQT : NASDAQ
GlobeNewswire
Arcutis Management to Present at TD Cowen's 46th Annual Health Care Conference
ARQT : NASDAQ
SeekingAlpha
Arcutis Earnings: Zoryve Dominance And Pipeline Catalysts Drive The Bull Case
ARQT : NASDAQ
KlickAnalytics
ARQT Price Target Alert: $34.00. Issued by H.C. Wainwright
ARQT : NASDAQ
SeekingAlpha
Arcutis Biotherapeutics, Inc. (ARQT) Q4 2025 Earnings Call Transcript
ARQT : NASDAQ
Motley Fool
Arcutis (ARQT) Q4 2025 Earnings Call Transcript
ARQT : NASDAQ
SeekingAlpha
Arcutis Biotherapeutics GAAP EPS of $0.13 beats by $0.03, revenue of $129.5M beats by $16.47M

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.